http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#head http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#assertion http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#provenance http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#publicationInfo http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#assertion http://bio2rdf.org/drugbank:DB00317 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00317_DB01030 http://bio2rdf.org/drugbank:DB01030 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00317_DB01030 http://bio2rdf.org/drugbank_resource:DB00317_DB01030 http://purl.org/dc/terms/identifier drugbank_resource:DB00317_DB01030 http://bio2rdf.org/drugbank_resource:DB00317_DB01030 http://purl.org/dc/terms/title DDI between Gefitinib and Topotecan - The BCRP/ABCG2 inhibitor, Gefitnib, may increase the bioavailability and serum concentration of oral Topotecan. Monitor for change in the therapeutic and adverse effects of Topotecan if Gefitinib is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00317_DB01030 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00317_DB01030 http://www.w3.org/2000/01/rdf-schema#label DDI between Gefitinib and Topotecan - The BCRP/ABCG2 inhibitor, Gefitnib, may increase the bioavailability and serum concentration of oral Topotecan. Monitor for change in the therapeutic and adverse effects of Topotecan if Gefitinib is initiated, discontinued or dose changed. [drugbank_resource:DB00317_DB01030] http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#provenance http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#publicationInfo http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#signature.MC0CFD3oI3aHjgWK http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#signature.MC0CFD3oI3aHjgWK http://purl.org/nanopub/x/hasSignature MC0CFD3oI3aHjgWKczWFgI9ztRtX/ncgAhUAlVfkhyVzm/OI4j8Wc+YM+DnOEL4= http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#signature.MC0CFD3oI3aHjgWK http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://purl.org/dc/terms/created 2018-03-30T11:12:53.136+02:00 http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ#signature.MC0CFD3oI3aHjgWK http://bio2rdf.org/drugbank_resource:DB00317_DB01030_nanopub.RA_33M6NTLwf-ZgPs9Kz_fjyxnNW0MPomHhKNx-08YmGQ http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234